Author: Gwon, Yong-Dae; Strand, Mårten; Lindqvist, Richard; Nilsson, Emma; Saleeb, Michael; Elofsson, Mikael; Överby, Anna K.; Evander, Magnus
                    Title: Antiviral Activity of Benzavir-2 against Emerging Flaviviruses  Document date: 2020_3_22
                    ID: 0ym40eki_7
                    
                    Snippet: The virus concentration of p0 stocks was determined by plaque assay, as previously described [23, 24] . Briefly, 500 µL of tenfold serial dilutions of the virus samples were added to a 6-well plate containing a confluent monolayer of Vero B4 cells. After 1 h incubation with shaking every 15 min, the virus suspension was discarded and an overlay was added that contained 2 mL of Dulbecco's modified Eagle medium (DMEM) with 2% FBS, 0.5% minimum ess.....
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: The virus concentration of p0 stocks was determined by plaque assay, as previously described [23, 24] . Briefly, 500 µL of tenfold serial dilutions of the virus samples were added to a 6-well plate containing a confluent monolayer of Vero B4 cells. After 1 h incubation with shaking every 15 min, the virus suspension was discarded and an overlay was added that contained 2 mL of Dulbecco's modified Eagle medium (DMEM) with 2% FBS, 0.5% minimum essential amino acids, 0.5% sodium pyruvate, 0.5% L-Glutamine, 1% penicillin/streptomycin, and 1% carboxymethylcellulose (CMC, Sigma Aldrich, St. Louis, MO, USA). After 4-5 days of incubation, the cells were fixed with 4% paraformaldehyde and stained with 1% crystal violet solution (1% crystal violet powder, 20% w/v methanol in distilled H 2 O). Plaques were counted and viral titers were calculated as plaque-forming units (PFUs)/mL.
 
  Search related documents: 
                                Co phrase  search for related documents- amino acid and essential amino acid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56
  - amino acid and previously describe: 1, 2, 3
  - amino acid and serial dilution: 1
  - amino acid and viral titer: 1, 2, 3, 4, 5, 6, 7
  - amino acid and virus sample: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
  - amino acid and virus suspension: 1, 2
  - confluent monolayer and crystal violet: 1
  - confluent monolayer and crystal violet solution: 1
  - confluent monolayer and penicillin streptomycin: 1
  - confluent monolayer and violet solution: 1
  - crystal violet and Eagle medium: 1, 2, 3
  - crystal violet and penicillin streptomycin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
  - crystal violet and plaque assay determine: 1, 2
  - crystal violet and sodium pyruvate: 1, 2
  - crystal violet and violet solution: 1, 2, 3, 4, 5, 6, 7, 8
  - crystal violet and viral titer: 1, 2
  - crystal violet and virus concentration: 1, 2
  - crystal violet and virus sample: 1
  - crystal violet powder and violet solution: 1
  
 
                                Co phrase  search for related documents, hyperlinks ordered by date